[LXRX] QoQ Quarter Result on 30-Sep-2024 [#Q3]

Stock
[LXRX] Lexicon Pharmaceuticals, Inc.
Announcement Date
13-Nov-2024
Financial Year
2024
Quarter
30-Sep-2024 [#Q3]
Profit Trend
QoQ- -21.30%
YoY- -28.28%
Quarter Report
LXRX's Result
LXRX's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Revenue 1,750 1,647 1,130 702 162 317 24 1631.77%
PBT -64,811 -53,429 -48,397 -48,244 -50,525 -44,904 -31,934 60.09%
Tax 0 0 101 -2,977 2,854 1,152 -1,029 -
NP -64,811 -53,429 -48,397 -48,244 -50,525 -44,904 -30,905 63.61%
Tax Rate - - - - - - - -
Total Cost 66,561 55,076 49,527 48,946 50,687 45,221 30,929 66.45%
Ratio Analysis
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
NP Margin -3,703.49 -3,244.02 -4,282.92 -6,872.36 -31,188.27 -14,165.30 -128,770.83 -90.55%
Per Share
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
EPS -0.18 -0.17 -0.20 -0.20 -0.21 -0.22 -0.16 8.14%
EPS Diluted -0.18 -0.17 -0.20 -0.20 -0.21 -0.22 -0.16 8.14%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.